1-1 of 1
Tarkan Sebil
Close
Sort by
Journal Articles

Targeting RAS Signaling in Multiple Myeloma (MM): Synergistic Inhibition by Co-Treatment with the MEK Inhibitor U0126 and Prenylation Inhibitors.

Christoph W.M. Reuter, MD/Ph.D., Michael A. Morgan, Ph.D., Tarkan Sebil, Arnold Ganser, MD/Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3398.
https://doi.org/10.1182/blood.V104.11.3398.3398
Published: 2004